JioMart's expansion to 200 cities across India over the weekend is a reason for worry to Amazon and Flipkart, according to Forrester analyst Satish Meena.
Amazon and Flipkart's weaknesses in grocery deliveries could be exploited by JioMart, which is backed by Asia's richest man Mukesh Ambani, Meena pointed out.
The announcement of expansion comes just days after JioMart raised over $10 billion in recent weeks, including a $5.7 billion investment from Facebook, forming a collaboration between JioMart and WhatsApp.
The timing for JioMart's expansion is perfect, as millions of Indians remain under lockdown due to the pandemic.
JioMart's goal is to get 30 million neighborhood mom and pop shops, called kiranas, to do business online.
The Indian retail market is expected to double in size from $676 billion in 2018 to nearly $1.3 trillion by 2025. It consists of 70 percent groceries, with over 90 percent unorganized and driven by kiranas.
Another advantage that favors JioMart is its ability to source supplies from the brick-and-mortar stores of Reliance, India's largest retail operator.


Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
REPAY Stock Rises After Visa Platform Connect Collaboration
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



